Communiqués Allergy Therapeutics plc

Actions

AGY

GB00B02LCQ05

Temps Différé London S.E. Autres places de cotation 11:14:59 18/07/2024			Varia. 5j.	Varia. 1 janv.
5,525 ^GBX	+0,45 %		+2,78 %	+122,00 %

27/06	Allergy Therapeutics plc nomme David Ball directeur non exécutif et président du comité d'audit et de risque du conseil d'administration	CI
10/06	GAGNANTS ET PERDANTS DE L'OBJECTIF : Arecor Therapeutics plonge en raison de ses besoins de financement	AN

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Allergy Therapeutics plc - Publication of Annual Report and Accounts 2023	31/01	AQ
Allergic Rhinitis Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)	28/09/23	AQ
Allergy Therapeutics plc - Publication of Annual Report and Accounts 2022	20/06/23	AQ
Allergy Therapeutics plc - Interim Results for the six months ended 31 December 2022 and Lifting of Suspension in Trading	20/06/23	AQ
Abbott Laboratories - Form 8.3 - Allergy Therapeutics PLC	21/04/23	PR
Allergy Therapeutics : 2022 Notice of Annual General Meeting	13/01/23	PU
Peanut Allergy Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Treatment Domain	09/12/22	AQ
ALLERGY THERAPEUTICS TUMBLES AFTER HALTING UK MANUFACTURING	05/10/22	AQ
Allergy Therapeutics shares positive new data at the 2022 American Academy of Allergy Asthma and Immunology Annual Meeting	02/03/22	AQ
Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut	26/01/22	AQ
Allergy Therapeutics : AGM 2021	24/11/21	PU
Allergy Therapeutics announces positive top line results from G309 exploratory field trial to evaluate efficacy and safety of Grass MATA MPL	25/10/21	GL
Preliminary Results for the Year ended 30 June 2021	23/09/21	GL
Allergy Therapeutics : Appointment of new Group auditors	19/04/21	AQ
Allergy Therapeutics : Interim Results for the six months ended 31 December 2020	04/03/21	AQ
Allergy Therapeutics : Half Year Trading Update 2021 and Notice of Results	14/01/21	AQ
Allergy Therapeutics : 2020 AGM Poll Vote Results	09/12/20	PU
Allergy Therapeutics : Notice of Meeting	10/11/20	PU
Allergy Therapeutics : Allergy Therapeutics plc Preliminary Results for the year ended 30 June 2020	23/09/20	AQ
ALLERGY THERAPEUTICS : BLOCK LISTING SIX MONTHLY RETURN	02/07/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Allergy Therapeutics plc

Actions

AGY

GB00B02LCQ05

Communiqués

Filtres